Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.590
+0.250 (7.49%)
At close: Dec 20, 2024, 4:00 PM
3.610
+0.020 (0.56%)
After-hours: Dec 20, 2024, 7:56 PM EST
Q32 Bio Stock Forecast
QTTB's stock price has decreased by -64.38% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 29.14, with a low estimate of 9.00 and a high estimate of 95. The average target predicts an increase of 711.70% from the current stock price of 3.59.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Q32 Bio stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 0 |
| Buy | 3 | 3 | 4 | 4 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 6 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +512.81% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 12, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $80 → $20 | Buy | Maintains | $80 → $20 | +457.10% | Dec 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $85 → $20 | Buy | Maintains | $85 → $20 | +457.10% | Dec 11, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $95 → $16 | Buy → Hold | Downgrades | $95 → $16 | +345.68% | Dec 11, 2024 |
Financial Forecast
Revenue This Year
n/a
from -6.65M
Revenue Next Year
n/a
EPS This Year
-5.73
from -7.41
EPS Next Year
-4.22
from -5.73
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -5.84 | -3.55 | -3.27 |
| Avg | -5.73 | -4.22 | -4.71 |
| Low | -5.53 | -5.32 | -5.92 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.